Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash Flows From Operating Activities
Net loss	$ (162,044)	$ (654,896)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	1,161	47,827
Gain on sale of assets and technology	(600,000)
Deferred rent amortization	6,056	(8,167)
Changes in operating assets and liabilities
Prepaid expenses and other assets	13,221	2,202
Accounts payable	(305,176)	6,198
Accrued liabilities	258,716	493,064
Other long term assets	(7,074)
Net cash used in operating activities	(795,140)	(113,771)
Cash Flows From Investing Activities
Purchase of fixed assets	(3,429)
Net cash used in investing activities	(3,429)
Cash Flows From Financing Activities
Cash advance from officer	(134,525)	(76,162)
Proceeds from note payable	181,156	145,076
Proceeds from preferred stock issuable	1,700,000
Cost on issuance of preferred shares	(166,891)
Net cash provided by financing activities	1,579,740	68,914
Net increase (decrease) in cash	781,171	(44,857)
Cash and cash equivalents at beginning of period	400	82,115
Cash and cash equivalents at end of period	781,571	37,258
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	9,153	6,507
Supplemental noncash financing activities:
Transfer of assets and technology in exchange for common stock issuable	$ 600,000